Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors

NCT00387322 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: erlotinib hydrochloride
DRUG: pemetrexed disodium

Sponsor

University of California, Davis

Collaborators

[object Object]